Alpha DNA Investment Management’s Blue Owl Capital OBDC Stock Holding History

Alpha DNA Investment Management’s Portfolio OBDC Stock Details OBDC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-29,903	Closed	-$452K	–	117
2024 Q4	$452K	Buy	29,903 +1,718	+6%	+$25.9K	0.17%	130
2024 Q3	$411K	Buy	28,185 +3,390	+14%	+$50.9K	0.15%	169
2024 Q2	$381K	Buy	24,795 +5,537	+29%	+$88.5K	0.15%	174
2024 Q1	$296K	Buy	19,258 +3,166	+20%	+$47.6K	0.11%	185
2023 Q4	$238K	Buy	+16,092	New	+$229K	0.09%	177
2023 Q3	–	Sell	-60,096	Closed	-$806K	–	207
2023 Q2	$806K	Sell	60,096 -23,598	-28%	-$309K	0.27%	93
2023 Q1	$1.06M	Buy	+83,694	New	+$1.08M	0.31%	101

Other funds holding OBDC

SONJCPFE

State of New Jersey Common Pension Fund E Trenton, New Jersey $77.7M AUM 25.18% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

OPERF

Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alpha DNA Investment Management's OBDC Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Blue Owl Capital (OBDC) in Q1 2025, closing a stake of 29,903 shares — an estimated $452K sold.

Alpha DNA Investment Management first reported a position in OBDC in Q1 2023 and held it in 7 quarters. The position peaked at $1.06M in Q1 2023. 438 funds tracked by Wall St. Rank hold OBDC as of Q1 2025.

Alpha DNA Investment Management reported no remaining Blue Owl Capital position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 29,903 Blue Owl Capital shares in Q1 2025, an estimated $452K.
Alpha DNA Investment Management first reported a position in Blue Owl Capital in Q1 2023 and held it in 7 quarters.
Alpha DNA Investment Management's Blue Owl Capital position peaked at $1.06M in Q1 2023.
438 funds tracked by Wall St. Rank held Blue Owl Capital as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.